Effects of ezetimibe +/- atorvastatin vs atorvastatin on cholesterol absorption and synthesis markers in high-risk patients with elevated C-reactive protein levels

Trial Profile

Effects of ezetimibe +/- atorvastatin vs atorvastatin on cholesterol absorption and synthesis markers in high-risk patients with elevated C-reactive protein levels

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Sep 2013

At a glance

  • Drugs Atorvastatin (Primary) ; Ezetimibe (Primary)
  • Indications Cardiovascular disorders; Lipid metabolism disorders
  • Focus Biomarker; Pharmacodynamics
  • Most Recent Events

    • 04 Sep 2013 Results presented at the ESC Congress 2013: Annual Congress of the European Society of Cardiology.
    • 29 Aug 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top